Ca 2+ signalling and exocytosis mediated by nicotinic receptor (nAChR) subtypes, especially the a7 nAChR, in bovine chromaffin cells are still matters of debate.
Introduction
Adrenal chromaffin cells derive from the neural crest and are innervated by the preganglionic cholinergic neurons of the splachnic nerve that release acetylcholine, the ligand that induces catecholamine secretion from chromaffin cells. Binding of the physiological neurotransmitter acetylcholine or nicotine to the nicotinic cholinoceptors (nAChR; receptor nomenclature follows Alexander et al., 2009 ) located in the plasma membrane of the chromaffin cell, opens the nicotinic receptor channel allowing the entry of sodium and calcium and the exit of potassium ions by means of an electrochemical gradient. The resultant depolarization of the membrane opens voltage-operated Ca 2+ channels (VOCCs) followed by Ca 2+ entry through these channels to trigger the release of catecholamines into the blood stream.
Neuronal nAChRs are pentameric ligand-gated channels, consisting of the same subunit type (homomeric) or different subunit types (heteromeric) . In bovine chromaffin cells, a3 (Criado et al., 1992) , a5 (Campos-Caro et al., 1997) b4 (Campos-Caro et al., 1997) and a7 (Garcia-Guzman et al., 1995) subunits have been cloned. Furthermore, a3, a5 and b4 transcripts are co-expressed in chromaffin cells and functional receptors have been obtained upon co-injection of these three subunit cRNAs into Xenopus oocytes (Campos-Caro et al., 1997) . In primary cultures of bovine chromaffin cells, most studies have shown that the nAChRs are insensitive to a-bungarotoxin (BGT) and there is wide agreement that they are involved in controlling catecholamine release.
As for the a7 nAChR, the presence of BGT-binding sites in the adrenal medullary chromaffin cells was first reported in 1977 (Wilson and Kirshner, 1977) . When the a7 nAChRs of the bovine chromaffin cell were cloned, injection in Xenopus oocytes of its cRNA produced BGT binding sites and functional acetylcholine currents sensitive to BGT (Criado et al., 1992) . Later on, BGT binding sites were described mainly in adrenergic but not in noradrenergic cells (Criado et al., 1997) . More recently, El-Hajj et al. (2007) have reported that the a7 homomeric population of nAChRs in bovine chromaffin cells was greater than the heteromeric nAChR population.
In terms of the control of catecholamine release, it is well established that Ca 2+ is required for this process, not only after a depolarizing pulse but also after nicotinic stimulation (Douglas and Rubin, 1961a,b) . After nAChR activation, the cytosolic concentration of Ca 2+ [Ca 2+ ]c is raised because of Ca 2+ entry through VOCCs (Rathouz and Berg, 1994) and by Ca 2+ -induced Ca 2+ -release (CICR) from intracellu-lar stores (Verkhratsky, 2002) . The VOCCs present in bovine chromaffin cells iclude the L, N and P/Q subtypes (Garcia et al., 2006) . Each VOCC subtype has been found to contribute to 45 Ca 2+ entry (Ballesta et al., 1989; Lopez et al., 1994; Villarroya et al., 1997) and catecholamine release (Lopez et al., 1994; Lara et al., 1998) . However, N and P/Q channels are inactivated at depolarizing voltages, in contrast to the L-subtype (Villarroya et al., 1999) , and this inactivation blocks Ca 2+ entry and catecholamine release (Artalejo et al., 1986; Michelena et al., 1993) .
Although Ca 2+ entry through the nicotinic receptor itself seems to contribute very little to [Ca 2+ ]c increase after receptor activation (Zhou and Neher, 1993) , Ca 2+ permeability associated with a particular nAChR subtype represents an important aspect of its physiological role in cellular processes. The homomeric a7 nAChR has the highest Ca 2+ : Na + permeability ratio (Seguela et al., 1993; Fucile et al., 2003) but desensitizes very rapidly (Couturier et al., 1990) in comparison with other nAChR subtypes. Another characteristic of the a7 nAChR is that nicotinic agonists bind to it with low affinity (Pereira et al., 1993) , although these receptors show high affinity for the antagonists BGT and methyllycaconitine (MLA).
As indicated before, the existence of a7 nAChRs in bovine chromaffin cells has been well documented by molecular techniques, but its functional relevance in terms of Ca 2+ signalling and catecholamine exocytosis is still a matter of debate. We therefore investigated this issue further, using new pharmacological tools such as the a7 nAChR agonist PNU282987 and the a7 nAChR allosteric modulator PNU120596.
Our results showed that activation of a7 nAChRs, in the presence of an allosteric modulator, can mediate BGT-sensitive [Ca 2+ ]c signals and catecholamine release. Furthermore, [Ca 2+ ]c increases mediated by a7 nAChR were related to Ca 2+ entry through non-L-VOCCs, whereas non-a7 nAChRmediated signals were related to L-type VOCCs. CICR also participated in both responses. Our results indicated that functionality of the a7 nAChR in chromaffin cells seems to require the binding of an allosteric modulator together with its agonist and that Ca 2+ signalling mediated through a7 and non a7 nAChR stimulation is differentially regulated in bovine chromaffin cells.
Methods
Isolation and culture of bovine chromaffin cells collagenase digestion as previously described (Livett, 1984) with some modifications (Moro et al., 1990) ; purification of bovine chromaffin cells was achieved by several consecutive centrifugations. Cells were suspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum, 50 IU·mL -1 penicillin and 50 mg·mL -1 streptomycin. Cells were pre-plated for 30 min and proliferation inhibitors (10 mM cytosine arabinoside, 10 mM fluorodeoxyuridine, and 10 mM leucine methyl ester) were added to the medium to prevent excessive growth of fibroblasts. Cultures were maintained in an incubator at 37°C in a water-saturated atmosphere with 5% CO2. Cells were used between 48 and 72 h post-plating.
Measurement of calcium signals with fluorescent dyes
Fluo-4 measurements in populations of bovine chromaffin cells. Bovine chromaffin cells were plated in black 96 well plates at a density of 200 000 cells per well. Cells were loaded with 4 mM Fluo-4/AM for 1 h at 37°C in DMEM. Then, cells were washed twice with Krebs-HEPES solution (composition (in mM): 140 NaCl, 5.6 KCl, 1.2 MgCl2, 2 CaCl2, 10 HEPES, 11 D-glucose, pH 7.4) and kept at room temperature for 30 min before the beginning of the experiment. When BGT (100 nM), mecamylamine (30 mM) nimodipine (3 mM) or w-conotoxin MVIIC (2 mM) were employed, these were incubated with the cells for 15 min before injecting the nicotinic agonists.
Fluorescence measurements were carried out for 10 s, as the agonists were injected in a microplate reader (FLUOstar Optima, BMG, Offenburg, Germany). Wavelengths of excitation and emission were 485 and 520 nm respectively.
At the end of the experiment, 75 mL of Triton (5%) was added to each well to calculate maximum fluorescence (Fmax) and then 50 mL of MnCl2 (1 M) to obtain the minimum fluorescence (Fmin). Drugevoked responses were expressed as percentage of the fluorescence values at each time point (F) minus minimum fluorescence values (F0) divided by Fmax -Fmin as follows:
The maximum value of F520, obtained for each experiment, was considered as the Peak F520 value.
Aequorin measurements. The construction of the aequorin chimeras targeted to either the cytosol or the mitochondria has been described previously (Rizzuto et al., 1992; Brini et al., 1995) . Chromaffin cells were plated on coverslips and infected with adenoviruses for expression of both constructs of targeted aequorin. Adenoviruses were prepared as described previously (Santodomingo et al., 2008) . Infection was carried out the day after cell isolation and Ca 2+ measurements were performed 48-72 h after infection. For aequorin reconstitution, cells expressing either cytosolic or mitochondrial aequorin were incubated for 1-2 h at room temperature with 1 mM of native coelenterazine in standard medium (145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM HEPES, pH 7.4). Cells were then placed in the perfusion chamber of a purpose-built luminometer maintained at 37°C. Calibration of the luminescence data into [Ca 2+ ] was made using an algorithm as previously described (Barrero et al., 1997) .
Catecholamine measurements
Bovine chromaffin cells were seeded in 12 well plates at a density of 500 000 cells per well. Catecholamines released from the cells were analyzed by highperformance liquid chromatography (HPLC; Agilent Technologies 1200 series) using electrochemical detection (BioRad, model 1640, Bio-Rad Laboratories, Irvine, CA, USA). A C18 reverse phase column (ZORBAX Eclipse XDB, Agilent Technologies, Santa Clara, CA, USA), eluted with a mobile phase (pH 4; 0.1 M sodium acetate, 0.1 M citric acid, 0.7 mM sodium octyl sulphate and 0.57 mM EDTA containing 10% methanol, v/v) was employed. The system was run continuously with the mobile phase being recycled back into the reservoir and used for up to one week. Flow rate was 1 mL·min -1 , at a pressure of 2200 psi. Fixed potentials against H2/H + reference electrodes were: conditioning electrode 0.4V; pre-oxidation electrode +0.10V; working electrode +0.35V. Adrenaline and noradrenaline concentrations were calculated from the chromatographic peak areas by using external standards. The chromatograms were collected, stored and processed with Clinical Data Management Software (BioRad CDM 1.10).
Data and statistical analysis
Data are given as means Ϯ SEM. Differences between groups were determined by applying a one-way ANOVA followed by Newman-Keuls test. In the aequorin experiments, Student's t-test was used to determine statistical differences between groups. Differences were considered to be statistically significant when P Յ 0.05.
Materials
Nicotine, choline, a-bungarotoxin (BGT), mecamylamine, cadmium, N-methyl glucamine, dimethyl sulfoxide (DMSO), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) and nimodipine were from Sigma (Madrid, Spain). PNU282987, PNU120596, 5-iodo-A-85380 dihydrochloride and w-conotoxin MVIIC from Tocris (Biogen Científica, Madrid, Spain). DMEM, fetal bovine serum and penicillin/streptomycin were purchased from Invitrogen (Barcelona, Spain). Fluo-4 AM and coelenterazine were from Molecular Probes (Invitrogen, Madrid, Spain).
Results
Nicotine and 5-iodo-A-85380 induce intracellular calcium signals that are not sensitive to BGT In Fluo-4 loaded chromaffin cells, addition of increasing concentrations of nicotine (0.03 to 100 mM) showed that this nicotinic agonist caused [Ca 2+ ]c increases in a concentration-dependent manner with an EC50 of 3.73 Ϯ 0.71 mM ( Figure 1C ). The [Ca 2+ ]c increases induced by nicotine were inhibited by mecamylamine but were unaffected by BGT (see Figure 1A for representative fluorescence tracings performed with 3 mM nicotine).
For comparative purposes we used another nAChR agonist, 5-iodo-A-85380, which has been described to have a fivefold higher affinity for a3b4 than for a7 nAChRs (Mukhin et al., 2000) . 5-Iodo-A-85380 (0.003 to 3 mM) produced concentrationdependent [Ca 2+ ]c signals with an EC50 of 0.11 Ϯ 0.01 mM ( Figure 1D ). As in the case of nicotine, the [Ca 2+ ]c increases following 5-iodo-A-85380 were fully blocked by mecamylamine, but were unaffected by BGT (see Figure 1B for representative fluorescence tracings performed with 100 nM 5-iodo-A-85380).
These results suggest that these two agonists, under these experimental conditions, stimulate non-a7 nAChRs and from now on we will refer to these responses as to non-a7.
Cytosolic calcium signals mediated by the a7 nAChR agonists PNU282987 and choline
We first used the selective a7 nAChR agonist PNU282987 . At concentrations ranging from 1 to 30 mM, PNU282987 failed to produce any significant [Ca 2+ ]c increase; however, at Figure C , when cells were stimulated by the nicotinic agonist 5-iodo-A-85380 (0.003-3 mM). Bars show the mean Ϯ SEM of five independent experiments; each experiment was performed in triplicate. *P < 0.05, **P < 0.01, ***P < 0.001; significantly different from agonist alone; one-way ANOVA followed by a post hoc Newman-Keuls test.
100 mM it caused a [Ca 2+ ]c increase that was completely blocked by mecamylamine but unaffected by BGT, suggesting that this calcium increase was due to stimulation of non-a7 nAChRs (Figure 2A ).
We also used the endogenous a7 nAChR agonist choline (Alkondon et al., 1997) . A similar pattern to that observed for PNU282987 was observed for this agonist. Choline did not induce a measurable [Ca 2+ ]c increase at concentrations ranging from 1 to 100 mM; at 1000 mM, choline gave a [Ca 2+ ]c signal that was blocked by mecamylamine but not by BGT ( Figure 2B ).
The a7 nAChR allosteric modulator PNU120596 potentiates the [Ca 2+ ] c increases induced by low concentrations of PNU282987, choline and nicotine: the modulated a7 nAChR response
We measured the effects of the a7 nAChR positive allosteric modulator PNU120596 on the [Ca 2+ ]c increases mediated by the a7 nAChR agonists PNU282987 and choline. Figure 3A illustrates a typical Fluo-4 recording showing that PNU282987 at 10 mM, a concentration that did not modify basal [Ca 2+ ]c (see Figure 2A ), increased by 12-fold the [Ca 2+ ]c signal in cells pre-treated with the a7 nAChR allosteric modulator PNU120596. This potentiated response was completely blocked by BGT. The a7 allosteric modulator potentiated responses to the a7 nAChR agonist PNU282987 (10 mM) in a concentration-dependent manner, with an EC50 of 0.89 Ϯ 0.14 mM and this modulated response was sensitive to BGT ( Figure 3B ).
We then performed a concentration responsecurve with PNU282987 in bovine chromaffin cells pre-treated with a fixed concentration of the a7 allosteric modulator PNU120596 (1 mM). Under these experimental conditions, we observed a 12-fold potentiation of the PNU282987 response, especially at those concentrations of PNU282987 that per se did not induce detectable [Ca 2+ ]c signals ( Figure 3C ). The potentiated responses were completely blocked by BGT, suggesting that they were mediated by a7 nAChRs. At higher concentrations of PNU282987 (10-100 mM), the proportion of the response that was sensitive to BGT was reduced ( Figure 3C ).
We also used the endogenous a7 nAChR agonist choline. In chromaffin cells pre-treated with the a7 nAChR allosteric modulator. The [Ca 2+ ]c signals induced by choline were significantly potentiated, most clearly at low concentrations and this potentiated response was fully blocked by BGT ( Figure 3D ). These results suggest that a7 nAChRs in chromaffin cells require the binding of an allosteric modulator together with lower concentrations of agonists to produce a measurable [Ca 2+ ]c signal, mediated by a7 nAChRs.
Lastly, we measured the [Ca 2+ ]c increases mediated by the non-specific nAChR agonist nicotine, in cells pre-incubated with PNU120596. The allosteric modulator was able to potentiate the [Ca 2+ ]c signal induced by low concentrations of nicotine (0.3 and 1 mM) ( Figure 4A ,C); the potentiated response was again fully blocked by BGT. However, concentrations of nicotine above 1 mM were not significantly potentiated by PNU120596 ( Figure 5B,C) . These results suggest that low concentrations of nicotine, in the presence of an a7 nAChR allosteric
Figure 2
Intracellular Ca 2+ responses induced by the a7 nicotinic acetylcholine receptor (nAChR) agonists PNU282987 and choline. Fluo-4 loaded bovine chromaffin cells were stimulated with increasing concentrations of the a7 nAChR agonists (A) PNU282987 (1-100 mM) or (B) choline (1-1000 mM). The antagonists mecamylamine (Mec; 30 mM) or a-bungarotoxin (BGT; 100 nM) were pre-incubated 15 min before injecting the agonists. Data represent the mean Ϯ SEM of four independent experiments; each experiment was performed in triplicate. #P < 0.05, ###P < 0.001, significantly different from agonist in the absence of antagonist. One-way ANOVA followed by a post hoc Newman-Keuls test.
modulator, can induce [Ca 2+ ]c increases via a7 nAChRs whereas, at concentrations above 1 mM, the allosteric potentiation is reduced and nicotine seems to induce [Ca 2+ ]c increases, predominantly, via non-a7 nAChRs.
Inactivation of the a7-nAChR-mediated [Ca 2+ ] c signals
To further understand the behavior of the a7 nAChRs in bovine chromaffin cells, we analyzed the kinetics of a7 [Ca 2+ ]c signals, mediated solely by a7 nAChRs, using PNU282987 as the agonist. Cells preincubated with a fixed concentration of PNU120596 (1 mM) alone or in the presence of BGT (100 nM), were stimulated with increasing concentrations of PNU282987 (1-100 mM) for 5 min to achieve a plateau in the a7 desensitization state. To estimate the response mediated solely by a7 nAChRs, for a given concentration of the agonist, we subtracted the response that was not blocked by 100 nM BGT (non-a7 response) from the total response (PNU 282987 + PNU 120596) (see Figure S1 for example). After this correction, the [Ca 2+ ]c signals changed as the concentration of the agonist was increased. The maximum peak of the [Ca 2+ ]c signal became lower as the concentration of the a7 nAChR agonist increased ( Figure 5 ). These results correlated with the reduction of the ton (activation time constant) and toff (inactivation time constant) (see Table 1 ). Most probably, the lower maximum peak of the [Ca 2+ ]c signals obtained with higher concentrations of the agonist could be related to greater inactivation of the a7 nAChR.
Participation of VOCCs in the [Ca 2+ ] c increases mediated by a7 and non-a7 nAChRs
To explore the contribution of the different VOCCs on the a7 and non-a7 nAChR responses, we preincubated the cells with a blocker of L-type (nimodipine, 3 mM) or a blocker of non-L-type (w-conotoxin MVIIC, 2 mM) VOCCs. As illustrated
Figure 3
Intracellular Ca 2+ responses induced by the a7 nicotinic acetylcholine receptor (nAChR) agonists PNU282987 and choline in the presence of the a7 allosteric modulator PNU120596. (A) Representative Fluo-4 fluorescence traces showing the calcium increase induced by 10 mM PNU282987 plus the allosteric modulator at 1 mM alone or in cells pre-treated with a-bungarotoxin (BGT) 100 nM. (B) The Ca 2+ signals induced by 10 mM PNU282987 were potentiated in a concentration-dependent manner by the allosteric modulator (from 0.1 to 30 mM) PNU120596; such potentiation was completely blocked in cells pre-treated with BGT 100 nM. (C,D) Concentration-response curves of PNU282987 (0.003-100 mM) and choline (1 mM-10 mM) in the presence of the a7 allosteric modulator PNU120596 (1 mM). Control cells were pre-incubated for 15 min in the presence of the same volume of DMSO (0.1% (v/v) which was used to assess the maximum concentration of PNU120596. Data represent the mean Ϯ SEM of four independent experiments; each experiment was performed in triplicate. **P < 0.01; ***P < 0.001; significantly different from agonists plus PNU120596: one-way ANOVA followed by a post hoc Newman-Keuls test.
in Figure 6A , the a7 nAChR-mediated [Ca 2+ ]c response (PNU282987 at 10 mM plus PNU120596 at 1 mM) (see Figure 3B ,C) was not affected by nimodipine. However, the non-L-type channel blocker, w-conotoxin MVIIC, decreased the Ca 2+ signal by 19.7 Ϯ 7% with respect to control. In contrast, the non-a7 nAChR response to nicotine at 10 mM (see Figure 1C ) was decreased by the L-type blocker nimodipine by 16.9 Ϯ 7.7% and was unaffected by w-conotoxin MVIIC ( Figure 6B ).
To further test the involvement of VOCCs in the [Ca 2+ ]c increases mediated by stimulation of these different nAChR subtypes, we used two other experimental tools: (i) the non-specific Ca 2+ channel blocker cadmium; and (ii) substitution of the extracellular Na + for N-methyl glucamine to prevent Na + -mediated depolarization. Both cadmium and N-methyl glucamine diminished the responses induced by a7 and non-a7 nAChRs. Blockade obtained by cadmium or Na + substitution by
Figure 4
Dual effect of nicotine on the a7 and non-a7 nicotinic acetylcholine receptors (nAChRs). (A) Representative traces of intracellular calcium measured as Fluo-4 fluorescence in cells stimulated with a low concentration of nicotine (1 mM); this response was potentiated by PNU120596 (1 mM) and such potentiation was fully blocked by a-bungarotoxin (BGT) 100 nM, an a7 nAChR response. (B) A similar experiment as earlier but at a higher concentration of nicotine (30 mM). In this case, the nicotinic response was unaffected by PNU120596 or BGT: a non-a7 nAChR response. (C) Concentration-response curve of nicotine alone (control) or in cells pre-incubated with PNU120596 (1 mM) alone or PNU120596 (1 mM) plus BGT (100 nM). The Ca 2+ signals induced by low concentrations of nicotine (0.3 and 1 mM) were potentiated by the allosteric modulator; this response was blocked by BGT. Ca 2+ increases induced by higher concentrations of nicotine (above 1 mM) were not significantly potentiated by PNU120596 and were not affected by BGT. Data represent the mean Ϯ SEM of five independent experiments; each experiment was performed in triplicate. *P < 0.05, significantly different from control. #P < 0.05, significantly different from nicotine plus PNU120596. One-way ANOVA followed by a post hoc Newman-Keuls test. To obtain the net a7 nAChR -mediated response, the non-a7 nAChR response, that is, the fluorescence increases that were not blocked by a-bungarotoxin, were subtracted from the PNU282987 + PNU120596 fluorescence value. Once these curves were obtained (see Figure 4) , ton, toff (seconds) and maximum peak were calculated.
N-methyl glucamine was not different to that obtained with w-conotoxin MVIIC in the case of a7 nAChR stimulation ( Figure 6A ) or nimodipine in the case of non-a7 nAChR stimulation ( Figure 6B ).
Magnitude and inactivation of a7 and non-a7 nAChRs-mediated [Ca 2+ ] c transients measured with cytosolic targeted aequorins
As the experimental conditions used above did not allow consecutive stimulation of the cells or quan-tification of the intracellular calcium concentration, we used another experimental approach that allowed superfusion of the cells, consecutive stimulation-washout cycles and estimation of the magnitude of the [Ca 2+ ]c transients. For this purpose we used chromaffin cells transfected with aequorins targeted to the cytosol (Montero et al., 2000) . Figure 7A shows a typical experiment. Addition of PNU282987 plus PNU120596 (at concentrations that gave an a7 nAChR-mediated response) produced a mean [Ca 2+ ]c peak around 200 nM, whereas perfusion of nicotine (at a concentration that gave a non-a7 nAChR response) produced larger peaks of around 600 nM (see statistics in Figure 7C ). The nicotine-induced [Ca 2+ ]c peak was also wider than that induced by PNU120596 plus PNU282987. Thus, when the total [Ca 2+ ]c response was measured in terms of area under the curve, the [Ca 2+ ]c response induced by the allosterically modulated a7 nAChRs was only 14 Ϯ 3% (mean Ϯ SEM = 6) of that induced by nicotine. When the cells were pre-treated with 100 nM BGT, an irreversible a7 nAChR antagonist, the [Ca 2+ ]c increase induced by PNU120596 plus PNU282987 was abolished whereas the nicotinic response remained unaltered ( Figure 7B,C) . These results indicated that with this new experimental approach, we could also distinguish between an a7 and non-a7-nAChR-mediated response.
When the cells were stimulated twice with nicotine, this agonist gave two [Ca 2+ ]c peaks of similar magnitude; however, a second stimulation with PNU120596 plus PNU282987 produced a much smaller response, indicating a slower recovery from
Figure 5
Intracellular Ca 2+ traces of pure a7 responses mediated by increasing concentrations of PNU282987 plus PNU120596 (1 mM). Mean traces of the net a7-nicotinic acetylcholine receptor (nAChR)-mediated Ca 2+ responses that correspond to increasing concentrations of the a7 nAChR agonist PNU282987 (1-100 mM) plus the a7 nAChR allosteric modulator PNU120596 at 1 mM. To obtain the net a7 nAChR response, we subtracted the non-a7 nAChR response, that is, the fluorescence increases that were not blocked by a-bungarotoxin from the PNU282987 + PNU120596 values. Data correspond to the mean of five independent experiments.
Figure 6
Effect of voltage operated calcium channels (VOCC) blockers on increases in intracellular Ca 2+ mediated by a7 and non-a7 nicotinic acetylcholine receptors (nAChRs). Cells were stimulated with PNU282987 10 mM + PNU 120596 1 mM (A), 10 mM nicotine (B), in the presence of 50 mM Cd 2+ (Cd), in Krebs-HEPES with N-methyl glucamine in substitution for sodium (gluc) or in the presence of the L-type VOCC blocker nimodipine (nimo 3mM;), or the non-L VOCC blocker w-conotoxin MVIIC (MVIIC 2 mM) during 10 s. Control cells, to compare with nimodipine, were supplemented with the same percentage of DMSO (0.1%) that was used to dissolve nimodipine. Data represent the mean and SEM of at least four independent experiments performed in triplicate. *P < 0.05, **P < 0.01; ***P < 0.001, significantly different from control: one-way ANOVA followed by a post hoc Newman-Keuls test.
inactivation (Figure 7D,E) . Similar results were given when the order of the agonists was changed. Figure 8A shows a representative trace of cells consecutively stimulated with PNU120596 plus PNU282987 (a7 nAChR response) and nicotine (non-a7 nAChR response) in control cells expressing cytosolic aequorin. To determine the contribution of the ER to the a7 and non-a7 nAChR-mediated [Ca 2+ ]c increase, we pre-treated the cells with thapsigargin, an irreversible blocker of the ER Ca 2+ pump (SERCA), 15 min before nicotinic agonist exposure. Emptying the ER Ca 2+ store with thapsigargin reduced, by over 80%, the [Ca 2+ ]c peaks induced by PNU120596 plus PNU282987 and by 60% the [Ca 2+ ]c peaks induced by nicotine ( Figure 8B,C) . These results were confirmed in chromaffin cells loaded with fluo-4 AM ( Figure S2 ). Contribution of the ER was significantly higher (P < 0.001; n = 3) for the a7 nAChR response, compared with the non-a7 nAChR response.
Contribution of the endoplasmic reticulum (ER) and mitochondria to the [Ca 2+ ] c and [Ca 2+ ] m transients induced by stimulation of a7 and non-a7 nAChR
The other intracellular organelle that participates in the regulation of intracellular calcium homeostasis is the mitochondria. We therefore measured mitochondrial [Ca 2+ ] ([Ca 2+ ]m) with aequorins targeted to this organelle. PNU120596 plus PNU282987 and nicotine elicited larger responses in the mitochondria (Figure 9A ,C) than those measured in the cytosol (Figure 9D,F) In addition, as could be expected, the [Ca 2+ ]m peaks induced by PNU120596 plus PNU282987 and nicotine were markedly reduced by the protonophore FCCP (Figure 9B,C) . However, mitochondrial depolarization with FCCP hardly modified [Ca 2+ ]c caused by a7 or non-a7 nAChR activation ( Figure 9E,F) . Therefore these results indicate that the ER but not the mitochondria participate in the [Ca 2+ ]c transients caused by stimulation of a7 and non-a7 nAChRs.
Catecholamine release induced by a7 and non-a7 nAChR stimulation
To determine if the Ca 2+ signals were functional in terms of inducing exocytosis, we measured, by HPLC, secretion of adrenaline and noradrenaline induced by a7 and non-a7 nAChR stimulation. Basal adrenaline release from 10 6 bovine chromaffin cells was 54 Ϯ 15 ng·mL -1 whereas that of noradrenaline was 84 Ϯ 25 ng·mL -1 . The a7 nAChR allosteric modulator PNU120596 at 10 mM did not modify basal levels of adrenaline or noradrenaline. However, in the presence of 10 mM PNU282987, adrenaline release increased to 191 Ϯ 38 ng·mL -1 (354% increase) and noradrenaline to 255 Ϯ 72 ng·mL -1 (305% increase); this catecholamine release was completely blocked by BGT ( Figure 10A ). Nicotine at 30 mM increased adrenaline release to 364 Ϯ 111 ng·mL -1 (674%) and noradrenaline to 
Figure 9
Contribution of the mitochondria to the mitochondrial and cytosolic Ca 2+ transients induced by stimulation of a7 or non-a7 nicotinic acetylcholine receptors (nAChRs). Bovine chromaffin cells expressing mitochondrially-or-cytosolic targeted aequorin were reconstituted with coelenterazine and then luminescence was monitored under continuous perfusion with 2 mM Ca 2+ -containing external medium. Left panels show representative traces of [Ca 2+ ]m transients induced by a7 (PNU282987 10 mM + PNU120596 10 mM) and non-a7 (nicotine 30 mM) nAChRs agonists, in control cells (A) and in cells treated with FCCP (2 mM), 2 min prior to the stimulus (B). (C) Summary data from several similar experiments as those shown in A and B. Right panels show representative traces of [Ca 2+ ]c induced by a7 (PNU282987 10 mM + PNU120596 10 mM) and non-a7 (nicotine 30 mM) nAChR agonists in control cells (D) and in cells treated with FCCP(2 mM), 2 min prior to and during the stimulus (E). (F) Summary data from several similar experiments as those shown in D and E. Data in panels C and F correspond to the mean and SEM of three to five independent experiments. *P < 0.05 and ***P < 0.001, significantly different from control.
Figure 10
Differential release of adrenaline and noradrenaline induced by a7 (A) and non-a7 (B) nicotinic acetylcholine receptor (nAChR) stimulation. Cells were stimulated for 30 s with both PNUs or nicotine and medium were collected to measure catecholamine release by high-performance liquid chromatography. Antagonists were pre-incubated for 5 min and were present during agonist stimulation. Bars show the mean Ϯ SEM from seven independent experiments. *P < 0.05, **P < 0.01, significantly different from PNU120596 alone for panel A or Krebs-HEPES for panel B. #P < 0.05, ##P < 0.01, significantly different from both PNUs for A or nicotine for B. The statistical analysis used was a one-way ANOVA followed by a post hoc Newman-Keuls test. 422 Ϯ 116 ng·mL -1 (502%); such secretion was fully blocked by mecamylamine ( Figure 10B ).
When normalized catecholamine release (total amount of catecholamines/basal catecholamines secreted) was divided by the normalized peak [Ca 2+ ]i (total peak [Ca 2+ ]i/basal [Ca 2+ ]i) the proportion obtained for the a7 nAChR response was 1.5 and for the non-a7 nAChR response was 0.6. These results suggest that for a given [Ca 2+ ]i peak, the modulated a7 nAChR stimulus secretes more catecholamines, by a factor of 2.5, than a non-a7 nAChR stimulus.
Discussion
Bovine chromaffin cells are a model extensively used to study calcium signalling and exocytosis, but the contribution of the different subtypes of nAChRs to the control of these parameters are still in debate, especially for the a7 nAChR subtype. By using new pharmacological and selective tools, we have systematically studied how activation of a7 and non-a7 nAChRs of bovine chromaffin cells mediated intracellular Ca 2+ signals and catecholamine secretion.
We first characterized the non-a7 nAChRmediated response. The intracellular Ca 2+ transients induced by nicotine and 5-iodo-A-85380 were related to non-a7 nAChRs, as they were fully blocked by mecamylamine but were unaffected by the a7 nAChR antagonist BGT. This non-a7 nAChR response was similar to those previously reported in bovine chromaffin cells and PC12 cells (Afar et al., 1994; Innocent et al., 2008) .
Because nicotine has been reported to act on different nAChR subtypes in PC12 cells (Nakayama et al., 2001) and in chick ciliary ganglion neurons (Vijayaraghavan et al., 1992) , we used PNU120596, an a7 nAChR allosteric modulator that is known to potentiate the a7 nAChR agonist response in PC12 and SHSY5Y cells (Dickinson et al., 2007; Innocent et al., 2008) . When we used PNU120596, which does not display any effect on a3b4 nAChRs expressed in Xenopus oocytes (Gronlien et al., 2007) , we observed that the minimal [Ca 2+ ]c transients induced by low concentrations of nicotine (1 mM or below) were markedly increased and that this potentiated response was fully blocked by the selective a7 nAChR antagonist BGT. However, nicotine at concentrations above 3 mM, provided concentrationdependent [Ca 2+ ]c transients in the absence of the allosteric modulator and this response was blocked by mecamylamine but not by BGT. Therefore, low concentrations of nicotine, in the presence of an a7 nAChR allosteric modulator, gave an a7 nAChR-modulated response, whereas high concentrations of nicotine alone give a non-a7 nAChR-mediated signal.
To further investigate how activation of a7 nAChRs could raise intracellular Ca 2+ and catecholamine secretion we used the selective a7 nAChR agonists like PNU282987 and choline. In spite of PNU282987 being highly selective for a7 nAChRs (Bodnar et al., 2005; Hajos et al., 2005) and showing almost negligible blockade by a3b4 nAChR antagonists (Wishka et al., 2006) , we found that this agonist, at concentrations ranging from 1 to 10 mM, did not induce measurable [Ca 2+ ]c increases. However at concentrations above 30 mM, it did induce [Ca 2+ ]c increases that were fully blocked by mecamylamine but were unaffected by BGT. We also found a similar pattern with the endogenous a7 nAChR agonist choline. In rat superior cervical ganglion neurones, such BGT-insensitive responses to choline have also been reported (Alkondon et al., 1997; Seddik et al., 2003) . However, in the presence of the a7 nAChR allosteric modulator PNU120596, the a7 nAChR agonist and choline, at concentrations that did not elicit measurable [Ca 2+ ]c increases by themselves, were markedly increased. These potentiated responses were completely blocked by BGT, indicating that it was an a7-nAChR-mediated response.
The activation and inactivation constants as well as the maximum peak of the a7 nAChR-mediated [Ca 2+ ]c responses decreased, as the concentration of the a7 nAChR agonist increased (Fatt, 1950; Katz and Thesleff, 1957) , suggesting a rapid desensitization of the receptor (Couturier et al., 1990) . The rapid inactivation of this receptor could also explain the loss of the a7 nAChR response at higher concentrations of the agonists.
The faster inactivating profile of the a7 nAChRmediated response was corroborated in the aequorin experiments, where a second stimulation with PNU282987 plus PNU120596 gave practically no response. However, two consecutive nicotine pulses, a non-a7 nAChR-mediated response, gave [Ca 2+ ]c transients of similar amplitude, i.e. there was hardly any inactivation. Although it has been reported that PNU120596 increases the mean opening time of the a7 nAChR channel even in the desensitized state (Bodnar et al., 2005; Gronlien et al., 2007) , our results ( Figure 4) suggest a time-dependent decrease of the Ca 2+ signal after prolonged exposure to the agonist.
Cell depolarization and participation of VOCCs in the [Ca 2+ ]c transients observed with PNU282987 plus PNU120596 (a7 response) and nicotine (non-a7 response) were corroborated with the N-methyl glucamine and cadmium experiments. Substitution of Na + by N-methyl glucamine, which prevents membrane depolarization mediating Na + entry through its channels, reduced the a7 and non-a7 nAChR-mediated increases in [Ca 2+ ]c to levels that were not statistically different to those obtained with w-conotoxin MVIIC in the case of the a7 response or nimodipine in the case of the non-a7 nAChR response. Moreover, the observation that the non-specific Ca 2+ channel blocker cadmium did not further increase the blockade of the [Ca 2+ ]c responses induced by nimodipine or w-conototoxin MVIIC in the a7 or non-a7-mediated responses, respectively, further supports the idea that non-Ltype Ca 2+ channels were coupled to the a7 nAChRs, whereas L-type Ca 2+ channels were coupled to non-a7 nAChRs.
Differential coupling of L and non-L-type VOCCs to a specific nAChR subtype can also contribute to the interpretation of the kinetics of the Ca 2+ signals mediated by these receptor subtypes, and the dual activation pattern of a given agonist. For example, Ca 2+ entry through L-type VOCCs favoured the inhibition of N and P/Q channels in voltage-clamped bovine adrenal chromaffin cells (Rosa et al., 2009) . Therefore, when a nicotinic agonist acts on non-a7 nAChRs, coupled to L-type Ca 2+ channels, the a7 nAChRs are inactivated because they are coupled to non-L Ca 2+ channels that inactivate more rapidly (Villarroya et al., 1999) . Also, depolarization itself can inactivate N-and-P/Q-type-Ca 2+ channels (Villarroya et al., 1999) that are more prone to inactivation than L-type Ca 2+ channels; this action translates into a reduction of [Ca 2+ ]c and catecholamine release (Artalejo et al., 1986; Michelena et al., 1993) . Therefore, rapid inactivation of a7 nAChRs could be related to the fact that they seem to be coupled to non-L-type Ca 2+ channels that inactivate faster, whereas non-a7 nAChRs, which are coupled to the slower inactivating L-type Ca 2+ channels, show less inactivation. However, in other systems like GH3 rat pituitary cells expressing homomeric a7 nAChR, [Ca 2+ ]c transients induced by ACh were blocked by isradipine, an L-type Ca 2+ channel antagonist (Feuerbach et al., 2005) .
Besides Ca 2+ entry through VOCCs, CICR from the ER can also contribute to the nAChR-mediated [Ca 2+ ]c transients. Our results in bovine chromaffin cells indicated that CICR made a major contribution to [Ca 2+ ]c transients upon nAChR stimulation, in comparison with Ca 2+ entry through VOCC. We also found, as previously reported in PC12 cells (Dickinson et al., 2007) , that CICR was a major contributor during a7 nAChR stimulation, when compared with non-a7 nAChR stimulation.
As to the participation of the mitochondria, the [Ca 2+ ]c transients induced by both a7 and non-a7 nAChRs were slightly and similarly amplified in this organelle, resulting in [Ca 2+ ]m transients of about twice the magnitude compared with the corresponding cytosolic transients. In spite of this observation, we did not observe significant differences between mitochondrial Ca 2+ uptake, relative to cytosolic Ca 2+ levels, which could be related to the nAChR subtype producing Ca 2+ entry. Moreover, blockade of mitochondrial Ca 2+ uptake with the protonophore FCCP produced no changes in the [Ca 2+ ]c peaks induced by either a7 or non-a7 nAChR responses, indicating that under these experimental conditions, mitochondrial Ca 2+ sequestration was relatively small and could not significantly modify the overall [Ca 2+ ]c transient. As shown before, massive Ca 2+ accumulation into mitochondria and its implication in catecholamine modulation requires the application of much more potent stimuli (Herrington et al., 1996; Montero et al., 2000; . Therefore in this case, the physiological significance of the observed increases in the [Ca 2+ ]m would be more related with the activation of energy production than with the buffering of cytosolic [Ca 2+ ].
Activation of postsynaptic nAChRs located in chromaffin cells, by acetylcholine, is responsible of catecholamine secretion under stressful conditions. The results of this study show that calcium entry through the modulated a7 nAChR seems to be more effective in inducing exocytosis, in comparison with the a3b4/ a3b4a5 receptor (Tachikawa et al., 2001) , in terms of secretion/[Ca 2+ ]c ratios. However, the magnitude of catecholamine release induced by nicotine, at concentrations related to non-a7 nAChRs was much higher compared with the a7nAChR -modulated response. The fact that a7 nAChRs seem to be coupled to non-L type VOCC, which have been described to be located closer to the exocytotic sites (Lopez et al., 1994; Lara et al., 1998) , could explain why Ca 2+ entry through this receptor seems to be more efficient in inducing exocytosis. Although it had been previously reported (Criado et al., 1997) that BGT-labelled cells were mainly adrenergic in adrenal slices, we have not found statistical differences between adrenaline and noradrenaline release when secretion was stimulated via a7 or non-a7 nAChRs. This finding could be probably attributed to differences in the preparation used; in this study we have employed isolated bovine chromaffin cells in culture instead of adrenal slices.
In conclusion, although the functional role of the a7 nAChR in the CNS has been well characterized (Barrantes et al., 1995; Meyer et al., 1998; Martin et al., 2004; Ulloa, 2005) , its functional properties in the peripheral nervous system have been less well defined (Fucile et al., 2005) . The expression density of this subtype of nAChR in plasma membranes from bovine chromaffin cells is similar ([ 125 I] aBGT 49.9 Ϯ 7.6 fmol·mg -1 protein) (El-Hajj et al., 2007) to those reported for rat hippocampal membranes ([ 125 I] aBGT 51.1 fmol·mg -1 protein) (Garcia-Guzman et al., 1995) . So, the question is why if bovine chromaffin cells express a7 nAChRs, most of the attempts to establish their functional role have produced negative results? (Afar et al., 1994; Tachikawa et al., 2001) . Nevertheless, we (Lopez et al., 1998) were able to partially block AChinduced calcium signals and catecholamine secretion with a selective a7 nAChR antagonist, which was an indirect indication to its participation in these processes. However, detection of calcium signals or exocytosis by direct activation of a7 nAChRs in these cells have yet not been clearly demonstrated. Our data offer at least three reasons why a functional role for the chromaffin a7 nAChRs, in terms of increasing cytosolic Ca 2+ and evoking catecholamine release, has been difficult to find: (i) the a7 nAChRs of bovine chromaffin cells need the presence of an allosteric modulator and low concentrations of agonists to achieve a measurable [Ca 2+ ]c transient; (ii) the magnitude of the [Ca 2+ ]c signal, compared with the non-a7nAChR -mediated response, is about 25%, in terms of maximum peak response, and around 15%, in terms of total calcium entry; and (iii) the a7 nAChR inactivates very rapidly.
In summary, the results of this study indicate that a7 nAChRs, in bovine chromaffin cells, are able to mediate measurable calcium signals and catecholamine exocytosis under circumstances that require an allosteric modulator and low concentrations of agonists. Notably, these requirements are not necessary for the effects mediated by the non-a7 nAChRs.
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Figure S1
To determine the pure a7 response (Trace C), we subtracted the response that was not blocked by 100 nM a-bungarotoxin (non-a7 response-Trace B) from the total response (PNU 282987 + PNU 120596-Trace A). Variables of Trace A and Trace B were performed in parallel in the same batches of cell cultures. Figure S2 Comparison of the contribution of the ER to the a7 and non-a7 nACh-mediated responses. Intracellular Ca 2+ was measured in bovine chromaffin cells loaded with Fluo-4AM using a fluorescence microplate reader as described in the Materials and Methods section. Blockade of the ER was achieved by treating the cells for 15 min with thapsigargin 1 mM prior to the addition of the nicotinic agonists. Data correspond to the mean and S.E.M of five experiments. ***P < 0.001 in comparison to control response. $$$ P < 0.001 comparing the a7 and non-a7 response in thapsigargin-treated cells.
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